Where our team of guest writers discuss what they think about the current NGP US Issues.
Manufacturers are juggling a plethora of issues in order to stay at the top
In September 2004, the FDA issued a final report on its Pharmaceutical Manufacturing Initiative (PMI).
Looking at checkweighers that reassure operators of compliant production, product completeness and repeatable quality control.
Looking at a product synonymous with innovation and quality in bioprocess equipment.
RNA interference (RNAi) emerged on the scene in the late 1990s as a previously recognized but relatively uncharacterized process in plants, fungi, and invertebrates.